Hemolysis and schistocytosis in the emergency department: consider pseudothrombotic microangiopathy related to vitamin B12 deficiency
|
|
- Ezra Campbell
- 5 years ago
- Views:
Transcription
1 Q J Med 2013; 106: doi: /qjmed/hct142 Advance Access Publication 10 July 2013 Hemolysis and schistocytosis in the emergency department: consider pseudothrombotic microangiopathy related to vitamin B12 deficiency N. NOËL 1, G. MAIGNÉ 1, G. TERTIAN 2,4, N. ANGUEL 3, X. MONNET 3,4, J.-M. MICHOT 1,4, C. GOUJARD 1,4 and O. LAMBOTTE 1,4 From the 1 APHP, Service de Médecine Interne, Hôpital Bicêtre, Le Kremlin Bicêtre, France, 2 APHP, Service d Hématologie Biologique, Hôpital Bicêtre, Le Kremlin Bicêtre, France, 3 APHP, Service de Réanimation Médicale, Hôpital Bicêtre, Le Kremlin Bicêtre, France and 4 Faculté de Médecine Paris-Sud 11, Université Paris-Sud, Le Kremlin Bicêtre, France Address correspondence to Professor O. Lambotte, MD, PhD, Service de Médecine Interne, Hôpital Bicêtre, 78, rue du Général Leclerc, F Le Kremlin Bicêtre cedex, France. olivier.lambotte@bct.aphp.fr Received 25 April 2013 and in revised form 14 June 2013 Summary Background: Hemolytic anemia with thrombocytopenia and schistocytosis is suggestive of thrombotic thrombocytopenic purpura (TTP). However, these features can occur in the context of vitamin B12 deficiency. Aim: To identify simple means of distinguishing between TTP and pseudothrombotic microangiopathies related to vitamin B12 deficiency (pseudo- TMA) at the bedside. Design and methods: Retrospective study of patients with pseudo-tma compared with patients with TTP. The patients with pseudo-tma were further compared with other cases of cobalamin deficiency, in order to detect factors associated with microangiopathic hemolysis during vitamin B12 deprivation. Results: Seven patients with pseudo-tma were compared with six patients with TTP. The pseudo- TMA patients had higher median lactate dehydrogenase (LDH) levels (7310 vs IU/l, P = 0.01), a higher platelet count (73 vs /l, P = ), a lower reticulocyte count (13.1 vs /l, P = ) and a lower neutrophil count (1.3 vs /l, P = ). When compared with 21 patients with vitamin B12 deficiency and anemia (but no schistocytosis), the pseudo-tma patients were more likely to present with pernicious anemia [7 out of 21 (33.3%) vs. 5 out of 7 (71.4%), respectively] and had lower vitamin B12 levels (105 vs. 45 mmol/l, respectively). Vitamin supplementation led to hematological improvements in all pseudo-tma patients. Conclusion: In a context of mechanical hemolysis with thrombocytopenia in a patient admitted to the emergency department, very high LDH levels and a low reticulocyte count are strongly suggestive of pseudo-tma and should prompt the physician to screen for cobalamin deficiency. Introduction Thrombotic microangiopathies (TMAs) are rare, severe conditions associated with a mortality rate of 10 20%. 1 The annual incidence of these conditions in France is four per million inhabitants. 2 Given that the lack of rapid plasma exchange is known to be an independent risk factor for shortterm mortality, 2 there is a need for rapid, reliable diagnostic tools that can help avoid treatment delays. 3 In this context, patients presenting in the! The Author Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please journals.permissions@oup.com
2 1018 N. Noël et al. emergency department with hemolytic anemia, schistocytosis and thrombocytopenia should be immediately screened for thrombotic thrombocytopenic purpura (TTP). However, differential diagnoses for microangiopathic hemolytic anemia have to be considered, such as malignant hypertension and Evans syndrome. 3 Besides these two conditions, rare situations mimicking TMA have been described in the context of vitamin B12 (cobalamin) deficiency. 4,5 These pseudo-tmas 4 can be confused with lifethreatening TTP if a vitamin B12 assay has not been performed. Hence, pseudo-tma patients presenting at the emergency department may be admitted to the intensive care unit (ICU) and undergo unnecessary, invasive treatments (such as plasma exchange). 5 In this study, we sought to describe the characteristics of patients with pseudo-tma related to vitamin B12 deficiency and compare them with patients admitted for TTP to a French tertiary university medical center over the same period. We further sought to identify simple clinical or biochemical features of pseudo-tma that could enable easier recognition of this condition in the emergency department. Methods Study design and setting Bicêtre University Medical Center is a primary and tertiary care institution in the southern suburbs of Paris, France. We retrospectively reviewed the medical records of patients admitted to our emergency department and subsequently transferred to the ICU or to our internal medicine department for hemolytic anemia associated with schistocytosis and thrombocytopenia (whether related to vitamin B12 deficiency or TMA) between 21 January 2005 and 01 January All patients were first identified using the ICD-10 classification for disclosure diagnoses, and the study data were then exhaustively extracted from these patients medical files. Selection of participants Patients were classified as having TTP if they had thrombocytopenia, microangiopathic hemolytic anemia, 3 low ADAMTS13 (A disintegrin and metalloproteinase with thrombospondin motifs) activity (<5%) and anti-adamts13 antibodies. The diagnostic criterion for pseudo-tma was vitamin B12 deficiency-associated anemia in combination with the biochemical and hematological features of hemolysis, schistocytosis and thrombocytopenia. Seven patients were diagnosed with pseudo-tma; their data at admission were compared with those of six patients admitted for TTP over the same period. In order to identify factors associated with microangiopathic hemolysis in a context of vitamin B12 deficiency, the seven patients with pseudo-tma were further compared with schistocytosis-free patients presenting with anemia related to B12 deficiency over the same period. Pernicious anemia was characterized via a gastric biopsy and an assay for anti-intrinsic factor antibodies. Food-cobalamin malabsorption was diagnosed as follows: documented cobalamin deficiency (<150 mmol/l), a sufficient daily intake of vitamin B12 (to exclude nutritional deficiency) and the existence of a predisposing factor (i.e. gastritis, alcoholism, proton-pump inhibitor exposure and metformin exposure). 6,7 This retrospective study was approved by our local institutional review board (Comité de Protection des Personnes Ile-de-France VII, n8pp ). Outcome measures N.N., G.W., G.T. and O.L. collected information on the patients medical history and clinical and biochemical parameters, with a particular focus on neurological symptoms (coma and objective abnormalities on neurological examination, such as hemiparesia and tetraparesia) and acute kidney failure (glomerular filtration rate <30 ml/min). Blood samples were carefully analyzed for hemolysisrelated parameters in particular [i.e. hemoglobin (g/l), lactate dehydrogenase (LDH; IU/l), haptoglobin (g/l) and bilirubin (mmol/l) levels, mean corpuscular volume (MCV, in fl), presence of schistocytes, platelet count, total white cell count (10 9 /l) and neutrophil count (10 9 /l)]. Schistocytes were characterized as previously described. 8 Bone marrow aspiration results were reported, when available. Statistical analysis Results are presented as the median (range) or n (%). A non-parametric Mann Whitney U test and Fischer s exact test or a 2 test (when applicable) were used for intergroup comparisons of continuous and categorical variables, respectively. The threshold for statistical significance was set to P < Data were analyzed using GraphPad Prism software (version 5.01, GraphPad Software Inc., La Jolla, CA, USA).
3 Pseudothrombotic microangiopathy due to vitamin B12 deficiency 1019 Results Comparison of pseudo-tma and TTP patients Seven patients were admitted for pseudo-tma during the study period. They had a median (range) hemoglobin level of 42 (35 79) g/l, a MCV of ( ) fl, a reticulocyte count of 13.1 ( ) 10 9 /l and a platelet count of 73 (38 145) 10 9 /l (Table 1). Schistocytosis was found in all seven patients. Three of the seven were admitted to the ICU for profound anemia and suspected TTP. One patient received 10 (ineffective) plasma exchanges. These data were compared with those from the six TTP patients (Table 1). All but one were transferred to the ICU prior to hospitalization in our internal medicine department. The TTP patients were younger than the pseudo-tma patients [median (range) age: 35.3 [ ] vs. 72 [43-78], respectively; P = 0.05). Five of the TTP patients (80%) had major organ involvement (neurological impairment in four of the six patients (66.6%) and severe kidney failure in two cases (33.3%)]. Importantly, none of the pseudo-tma patients had acute kidney failure, but two displayed confusion. Table 1 Comparison of pseudo-tma and TTP groups Compared with the TTP patients, pseudo-tma patients had higher platelet counts [median (range): 12.5 (8 41) vs. 73 (38 145) 10 9 /l, respectively; P = ), lower white blood cell counts [7.0 ( ) vs. 3.4 ( ) 10 9 /l, respectively; P = ] and lower neutrophil counts [5.1 (3.4 10)] vs. 1.3 ( ) 10 9 /l, P = ]. The most marked differences were related to hemolytic features: reticulocyte counts were significantly lower in pseudo-tma patients than in TTP patients [13.1 ( ) vs ( ) 10 9 /l, respectively; P = ] and LDH levels were significantly higher [7310 ( ) vs ( ) IU/l, respectively; P = 0.01]. Characteristics of patients with anemia and vitamin B12 deficiency In order to better characterize the pseudo-tma condition, we performed an overall, descriptive analysis of the patients admitted for anemia and vitamin B12 deficiency to the internal medicine department. Patients who were not subsequently hospitalized were not included in the analysis. A total of 28 patients had cobalamin deficiency-related anemia Pseudo-TMA (n = 7) TTP (n = 6) P-value Clinical characteristics Male, n (%) 5 (71.4) 2 (33.3) 0.17 Age at hospitalization (years) 72 (43 78) 35.2 ( ) 0.05 Caucasian origin, n (%) 3 (42.9) 4 (66.7) 0.59 Neurological symptoms, n (%) 2 a (28.6) 4 (66.6) 0.17 Acute kidney failure, n (%) 0 (0) 2 (33.3) 0.10 Hematological characteristics Hemoglobin (g/l) 42 (35 79) 69 (49 110) 0.07 Schistocytes, n (%) 7 (100) 6 (100) 1 Reticulocyte count (10 9 /l) 13.1 ( ) ( ) Mean corpuscular volume (fl) ( ) 92 (82 118) 0.05 Platelet count (10 9 /L) 73 (38 145) 12.5 (8 41) White blood cell count (10 9 /l) 3.4 ( ) 7.0 ( ) Neutrophil count (10 9 /l) 1.3 ( ) 5.1 (3.4 10) Neutropenia (< /l), n (%) 2 (28.6) 0 (0) 0.15 Pancytopenia, n (%) 2 (28.6) 0 (0) 0.15 Hemolysis and biochemical patterns LDH (IU/l, Normal <480) 7310 ( ) 1460 ( ) 0.01 Haptoglobin (g/l, Normal >0.2) 0.1 ( ) 0.08 ( ) 0.75 Bilirubin (mmol/l, Normal <10) 21 (16 49) 25 (5 85) 0.72 Outcome Length of hospital stay (days) 14 (5 26) 34 (9 45) 0.03 a The neurological symptom for these two patients was mild confusion (probably caused by anemia). Results are shown as the median (min max) or number of patients, n (%).
4 1020 N. Noël et al. Table 2 Clinical and biochemical characteristics of our patients with anemia and vitamin B12 deficiency Pseudo-TMA (n = 7) No schistocytosis (n = 21) P-value Clinical characteristics Male, n (%) 5 (71.4) 10 (47.6) 0.27 Age at hospitalization (years) 72 (43 78) 54 (27 92) 0.22 Caucasian origin, n (%) 3 (42.9) 16 (76.2) 0.17 Mild confusion, n (%) 2 (28.6) 4 (19) 0.59 Acute kidney failure, n (%) 0 (0) 0 (0) 1 Hematological characteristics Hemoglobin (g/l) 42 (35 79) 61 (31 116) 0.19 Hemoglobin <60 g/l, n (%) 5 (71.4) 10 (47.6) 0.27 Schistocytes, n (%) 7 (100) 0 (0) < Reticulocyte count (10 9 /l) 13.1 ( ) 26.0 ( ) 0.22 Mean corpuscular volume (fl) ( ) ( ) 0.46 Platelet count (10 9 /l) 73 (38 145) 111 (24 307) 0.27 White blood cell count (10 9 /l) 3.4 ( ) 4.7 ( ) 0.17 Neutrophil count (10 9 /l) 1.3 ( ) 2.9 ( ) 0.01 Neutropenia (< /l), n (%) 2 (28.6) 0 (0) 0.01 Pancytopenia, n (%) 2 (28.6) 0 (0) 0.01 Hemolysis and biochemical patterns LDH (IU/l, N < 480) 7310 ( ) 2950 ( ) 0.08 Haptoglobin (g/l, N > 0.2) 0.1 ( ) 0.09 ( ) 0.39 Bilirubin (mmol/l, N < 10) 21 (16 49) 25.5 (4 51) 0.93 Vitamin levels Vitamin B12 (mmol/l, N > 150) 45 (15 111) 105 (15 145) 0.07 Folic acid (nmol/l, N > 15) 17.5 (1 34) 9 (1 54) 0.90 Etiology of vitamin B12 deficiency Pernicious anemia, n (%) 5 (71.4) 7 (33.3) 0.08 Food cobalamin malabsorption, n (%) 1 (14.3) 10 (47.6) 0.12 Nutritional deficiencies, n (%) 1 (14.3) 2 (9.5) 0.72 Post-surgical malabsorption, n (%) 0 (0) 2 (9.5) 0.40 Outcome of vitamin B12 therapy Reticulocyte increase (day) 5 (1 9) 5 (2 10) 1 Length of hospital stay (days) 14 (5 26) 10 (2 37) 0.23 Results are shown as the median (min max) or number of patients, n (%) (i.e. the seven pseudo-tma patients and 21 patients without schistocytosis). The median (range) age of the 28 patients was 56 (27 92) years. Overall causes of deficiency were pernicious anemia (n = 12), food-vitamin B12 malabsorption (n = 11), nutritional deficiency (n = 3) and gastric surgery (n = 2). Although six patients presented with mild confusion, none had symptoms of sensorimotor neuropathy or kidney failure. When we compared the seven pseudo-tma patients with the schistocytosis-free 21 patients, we did not observe any significant difference in age at admission or the gender ratio. Although the two groups had similar hemoglobin levels and platelet counts, the pseudo-tma group had a lower neutrophil count and a greater frequency of pancytopenia (Table 2). Bone marrow aspiration was performed in four pseudo-tma patients and 12 schistocytosisfree patients and yielded similar results in the two groups (i.e. megaloblastosis, dyserythropoiesis and/ or hypersegmented neutrophils). Consistently, the vitamin B12 levels in the pseudo-tma group were half those in the non-pseudo-tma group [median (range): 45 (15 111) vs. 105 (15 145) mmol/l, respectively; P = 0.07]. The main cause of vitamin B12 deficiency in the pseudo-tma group was pernicious anemia. Overall, the treatment consisted of vitamin B12 (1000 mg/day) and folic acid supplementation. For the 28 patients as a whole, the reticulocyte count (reflecting bone marrow regeneration) rose to 293 (92 684) g/l on Day 5 (range: 1 9). All patients improved with vitamin supplementation. Discussion We described seven patients with vitamin B12 deficiency associated with pseudo-tma and compared
5 Pseudothrombotic microangiopathy due to vitamin B12 deficiency 1021 their characteristics with those of six TTP patients. A presentation of pseudo-tma appears to be associated with very low vitamin B12 levels and pernicious anemia. Very elevated LDH levels and a low reticulocyte count were always found. These features are more suggestive of pseudo-tma than TTP and should prompt the physician to screen for vitamin B12 deficiency. Vitamin B12 deficiency is frequent in the general population and can affect up to 15% of the elderly. 9,10 Moreover, pseudo-tma accounts for 2.5% of the hematological disorders related to vitamin B12 deficiency, 6 although few cases have been reported. 4,5 Interestingly, when compared with vitamin B12-deficient patients not displaying schistocytosis, patients in the pseudo-tma group had a lower neutrophil count and a higher incidence of pancytopenia. This more severe presentation may be related to the 2-fold lower vitamin B12 levels seen in pseudo-tma patients. According to the literature, pernicious anemia accounts for the majority of cases of pseudo-tma, 4,5 whereas malabsorption tends to be associated with a milder presentation. To the best of our knowledge, this is the first study to have compared pseudo-tma and TTP patients. Interestingly, over a 4-year period, the same number of patients with each condition was admitted to the emergency department emphasizing that although these conditions are infrequent, they can be encountered in routine practice. Our results are consistent with the fact that pseudo-tma related to cobalamin deficiency must be considered as a differential diagnosis of TTP in a setting of microangiopathic hemolytic anemia (along with autoimmune hemolysis and malignant hypertension). 3 Although pseudo-tma may mimic life-threatening TTP, 5 there are some important clinical differences. Acute kidney failure is suggestive of TTP and was not observed in our seven pseudo- TMA patients. None of the latter had severe, acute neurological symptoms (such as drowsiness or coma, which are symptoms of TTP) but two did show confusion which can also be a symptom of TTP. The combination of a low reticulocyte count and very high LDH levels is suggestive of intramedullary hemolysis, 6 whereas blood smear features such as macro-ovalocytosis and hypersegmented polymorphonuclear cells suggest megaloblastic hematopoiesis. However, a reticulocyte count and a blood smear analysis are not always among the first battery of laboratory investigations performed at admission especially at night. Here, we observed that LDH levels were much higher in pseudo-tma related to vitamin B12 deficiency, whereas bilirubin levels were not as high as expected. 11 This may be related to the fact that LDH enzymes are released during the destruction of nucleated cells (i.e. young erythroblasts in the bone marrow) but not the destruction of mature red blood cells. Furthermore, erythroid progenitors produce little hemoglobin and only low levels of free bilirubin can be released. Finally, patients with pseudo-tma displayed a high MCV. In the setting of hemolytic disorders, a high MCV can be observed due to high reticulocyte count, which is not the case in intramedullary hemolysis. Indeed, physicians should be aware that in case of hemolysis, a high MCV despite a low-tonormal reticulocyte count is strongly suggestive of B12 of folic acid deficiency rather than TTP. This study emphasizes the existence of schistocytosis in both pseudo-tma and TTP. In TTP, schistocytes result from mechanical fragmentation on fibrin strands. However, cytoskeletal fragility is responsible for erythroblast fragmentation in dyserythropoiesis (such as in vitamin B12 deficiency) and major differential diagnoses (such as other acquired dyserythropoiesis or hematological malignancies) should also be considered. 8 We suggest that the bone marrow cytology should be analyzed in cases of aregenerative anemia with schistocytosis. Our study had a number of limitations. First, this was a retrospective analysis conducted in a single center (explaining the low number of enrolled patients). However, this process guaranteed the uniformity of the collected data. The small sample size means that some observed trends toward differences between pseudo-tma patients and the other patients with cobalamin deficiency might become statistically significant in a larger series (e.g. vitamin B12 levels or the proportion of patients with pernicious anemia). Despite these caveats, we believe that our results provide a useful means of rapidly differentiating between TTP on one hand and vitamin B12 deficiency-associated pseudo-tma on the other, in order to adjust patient management in an emergency setting. In conclusion, pseudo-tma related to vitamin B12 deficiency may mimic TTP. However, the marked elevation of LDH and the absence of an elevated reticulocyte count should guide the physician toward a diagnosis of pseudo-tma related to vitamin B12 deficiency. Prompt recognition of pseudo-tma should help to avoid the administration of unnecessary and invasive therapies. Acknowledgements N.N., G.M., G.T., N.A., X.M., J.M.M. collected the data; N.N. and O.L. performed the analysis and wrote the manuscript; N.N., G.M., G.T., N.A.,
6 1022 N. Noël et al. X.M., J.M.M., C.G. and O.L. reviewed and approved the final manuscript. Conflict of interest: None declared. References 1. Benhamou Y, Assié C, Boelle PY, Buffet M, Grillberger R, Malot S, et al. Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiencyassociated idiopathic thrombotic thrombocytopenic purpura: The French TMA Reference Center experience. Haematologica 2012; 97: Peigne V, Perez P, Resche Rigon M, Mariotte E, Canet E, Mira JP, et al. Causes and risk factors of death in patients with thrombotic microangiopathies. Intensive care med 2012; 38: Scully M, Hunt BJ, Benjamin S, Liesner R, Rose P, Peyvandi F, et al. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol 2012; 158: Andrès E, Affenberger S, Federici L, Korganow AS. Pseudo-thrombotic microangiopathy related to cobalamin deficiency. Am J Med 2006; 119:e3. 5. Garderet L, Maury E, Lagrange M, Najman A, Offenstadt G, Guidet B. Schizocytosis in pernicious anemia mimicking thrombotic thrombocytopenic purpura. Am J Med 2003; 114: Andrès E, Affenberger S, Zimmer J, Vinzio S, Grosu D, Pistol G, et al. Current hematological findings in cobalamin deficiency. A study of 201 consecutive patients with documented cobalamin deficiency. Clin Lab Haematol 2006; 28: Andrès E, Affenberger S, Vinzio S, Kurtz JE, Noel E, Kaltenbach G, et al. Food-cobalamin malabsorption in elderly patients: Clinical manifestations and treatment. Am J Med 2005; 118: Lesesve JF, Asnafi V, Braun F, Zini G. Fragmented red blood cells automated measurement is a useful parameter to exclude schistocytes on the blood film. Int J Lab Hematol 2012; doi: /j x x. [Epub ahead of print]. 9. Stabler SP. Clinical practice. Vitamin B12 deficiency. N Engl J Med 2013; 368: Lindenbaum J, Rosenberg IH, Wilson PW, Stabler SP, Allen RH. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr 1994; 60: Moake JL. Thrombotic microangiopathies. N Engl J Med 2002; 347:
Therapeutic dilemma in the management of a patient with the clinical picture of TTP and severe B 12 deficiency
Walter et al. BMC Hematology (2015) 15:16 DOI 10.1186/s12878-015-0036-2 CASE REPORT Therapeutic dilemma in the management of a patient with the clinical picture of TTP and severe B 12 deficiency Kara Walter
More informationThings to never miss in the office. Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC
Things to never miss in the office Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC Presenter Disclosure Faculty / Speaker s name: Brett Houston / Leonard Minuk Relationships with commercial
More informationDRUG NAME: Eculizumab Brand(s): Soliris DOSAGE FORM/ STRENGTH: 10 mg/ml (300 mg per vial)
Preamble: A confirmed diagnosis of atypical hemolytic uremic syndrome (ahus) is required for eculizumab funding. The information below is to provide clinicians with context for how a diagnosis of ahus
More informationWhat is meant by Thrombotic Microangiopathy (TMA)?
What is meant by Thrombotic Microangiopathy (TMA)? Thrombotic Microangiopathy (TMA) is a group of disorders characterized by injured endothelial cells, microangiopathic hemolytic anemia (MAHA), with its
More informationAtypical Hemolytic Uremic Syndrome: When the Environment and Mutations Affect Organ Systems. A Case Report with Review of Literature
Atypical Hemolytic Uremic Syndrome: When the Environment and Mutations Affect Organ Systems. A Case Report with Review of Literature Mouhanna Abu Ghanimeh 1, Omar Abughanimeh 1, Ayman Qasrawi 1, Abdulraheem
More informationApproccio morfologico alle microangiopatie trombotiche
Approccio morfologico alle microangiopatie trombotiche Gina Zini Polo Oncologia e Ematologia Policlinico A. Gemelli Università Cattolica S. Cuore - Roma 1 Thrombotic microangiopathies Occlusive microangiopathic
More informationYear 2003 Paper two: Questions supplied by Tricia
QUESTION 65 A 36-year-old man presents in a post-ictal state after an observed generalised seizure. Full blood investigation shows: haemoglobin 0 g/l [128-175] mean corpuscular volume (MCV) 106 fl [80-7]
More informationDoes Morphology Matter in 2017
Does Morphology Matter in 2017 ISLH May 2017 Kathryn Foucar Distinguished Professor Emerita kfoucar@salud.unm.edu Objectives Recognize unique RBC and WBC abnormalities in non-neoplastic disorders Learn
More informationNew insights in thrombotic microangiopathies : TTP and ahus
New insights in thrombotic microangiopathies : TTP and ahus Dr Catherine LAMBERT Hematology Cliniques universitaires Saint-Luc Catherine.lambert@uclouvain.be New insights in thrombotic microangiopathies
More informationThe utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry
research paper The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry Sevda Hassan, 1 John-Paul Westwood, 2 Debra Ellis, 2 Chris
More informationBeyond Plasma Exchange: Targeted Therapy for Thrombotic Thrombocytopenic Purpura
Beyond Plasma Exchange: Targeted Therapy for Thrombotic Thrombocytopenic Purpura Kristen Knoph, PharmD, BCPS PGY2 Pharmacotherapy Resident Pharmacy Grand Rounds April 25, 2017 2016 MFMER slide-1 Objectives
More informationDR V PHILIP CLINICAL HAEMATOLOGY UNIT CHRIS HANI BARAGWANATH ACADEMIC HOSPITAL
DR V PHILIP CLINICAL HAEMATOLOGY UNIT CHRIS HANI BARAGWANATH ACADEMIC HOSPITAL Rare but fatal disease if unrecognized and untreated Incidence about 1: 1 million in the USA Female preponderance of 2:1 Part
More informationPresentation Outline. Disease Background Previous research on platelet recovery rate Goal of our study Methods Results Limitations Conclusions
Platelet Recovery Rate at Day 5 of Therapeutic Plasma Exchange for Acquired Thrombotic Thrombocytopenic Purpura Can Aid in Identifying Risk of Disease Exacerbation Suzanne Zhou, Yara A. Park, Marian A.
More informationUpdates for your practice August 2013 TLALELETSO. HIV & Anemia. Continued on Page 2
dates for your practice August 2013 TLALELETSO HIV & Anemia In this issue we review anemia and HIV. Medical professionals across all disciplines need to be alert to the hematological complications of HIV
More informationmonoclonal gammopathy of undetermin Citation Rheumatology international, 33(1),
NAOSITE: Nagasaki University's Ac Title Author(s) Renal thrombotic microangiopathies/ in a patient with primary Sjögren's monoclonal gammopathy of undetermin Koga, Tomohiro; Yamasaki, Satoshi; Atsushi;
More informationHAEMATOLOGICAL EVALUATION OF ANEMIA. Sitalakshmi S Professor and Head Department of Clinical Pathology St John s medical College, Bangalore
HAEMATOLOGICAL EVALUATION OF ANEMIA Sitalakshmi S Professor and Head Department of Clinical Pathology St John s medical College, Bangalore Learning Objectives Laboratory tests for the evaluation of anemia
More informationMost Common Hemostasis Consults: Thrombocytopenia
Most Common Hemostasis Consults: Thrombocytopenia Cindy Neunert, MS MSCS Assistant Professor, Pediatrics CUMC Columbia University TSHNA Meeting, April 15, 2016 Financial Disclosures No relevant financial
More informationAnemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi
Anemia (3).ms4.25.Oct.15 Hemolytic Anemia Abdallah Abbadi Case 3 24 yr old female presented with anemia syndrome and jaundice. She was found to have splenomegaly. Hb 8, wbc 12k, Plt 212k, retics 12%, LDH
More informationThrombotic thrombocytopenic purpura: a look at the future
Thrombotic thrombocytopenic purpura: a look at the future Andrea Artoni, MD Ph.D. Angelo Bianchi Bonomi Hemophilia and Thrombosis Center IRCCS Ca Granda Ospedale Maggiore Policlinico Milan, Italy andrea.artoni@policlinico.mi.it
More informationCase Report Vitamin B12 Deficiency and Hemoglobin H Disease Early Misdiagnosed as Thrombotic Thrombocytopenic Purpura: A Series of Unfortunate Events
Hindawi Publishing Corporation Case Reports in Hematology Volume 2015, Article ID 478151, 5 pages http://dx.doi.org/10.1155/2015/478151 Case Report Vitamin B12 Deficiency and Hemoglobin H Disease Early
More informationSoliris (eculizumab) DRUG.00050
Market DC Soliris (eculizumab) DRUG.00050 Override(s) Prior Authorization Approval Duration 1 year Medications Soliris (eculizumab) APPROVAL CRITERIA Paroxysmal Nocturnal Hemoglobinuria I. Initiation of
More informationI. Definitions. V. Evaluation A. History B. Physical Exam C. Laboratory evaluation D. Bone marrow examination E. Specialty referrals
I. Definitions II. III. Red blood cell life cycle Iron metabolism IV. Causes of anemia A. Kinetic approach 1. decreased production 2. increased destruction 3. blood loss B. Morphologic approach 1. normocytic
More information(anemia) ก hemoglobin concentration, hematocrit deviation 1 1 ก hemoglobin, hematocrit mean corpuscular volume (MCV) 2
ก ก. ก ก.. ก (anemia) ก hemoglobin concentration, hematocrit ก ก ก 2 Standard deviation 1 1 ก hemoglobin, hematocrit mean corpuscular volume (MCV) 2 Hemoglobin hematocrit MCV (g/dl) (%) (fl) ( ) 0.5-1.9
More informationComparative Evaluation of Schistocyte Counting by an Automated Method and by Microscopic Determination
Hematopathology / AUTOMATED AND MICROSCOPIC SCHISTOCYTE COUNTING Comparative Evaluation of Schistocyte Counting by an Automated Method and by Microscopic Determination Jean-François Lesesve, MD, 1 Sylvain
More informationORIGINAL ARTICLE CLINICO PATHOLOGICAL REVIEW OF MEGALOBLASTIC ANAEMIA IN CHILDREN- A 7 YEAR PAEDIATRIC HOSPITAL EXPERIENCE
CLINICO PATHOLOGICAL REVIEW OF MEGALOBLASTIC ANAEMIA IN CHILDREN- A 7 YEAR PAEDIATRIC HOSPITAL EXPERIENCE M.Ramani 1, D.Ranganath 2,O.H.RadhikaKrishna 3, K.Geetha 4, M.Keerthika 5, PujaDeshmukh 6, S.P.Krupani7,
More informationRole Of Complete Blood Count In Analysis Of Macrocytosis In Adult Patient Dr Sarat Das 1, Dr Navanita Das 2 1
International Journal Of Medical Science And Clinical Inventions Volume 2 issue 07 page no. 1179-1184 ISSN: 2348-991X Available Online At: http://valleyinternational.net/index.php/our-jou/ijmsci Role Of
More informationLet`s go for the diagnosis! Yazeed Toukan, MD Pediatric Pulmonary Institute, Ruth Rappaport Children`s Hospital July 2016
Let`s go for the diagnosis! Yazeed Toukan, MD Pediatric Pulmonary Institute, Ruth Rappaport Children`s Hospital July 2016 Case report 20 months old girl Israeli Arab Muslim family, consanguineous marriage
More informationAnemia (3).ms Hemolytic Anemia. Abdallah Abbadi Feras Fararjeh
Anemia (3).ms4.26.2.18 Hemolytic Anemia Abdallah Abbadi Feras Fararjeh Case 3 24 yr old female presented with anemia syndrome and jaundice. She was found to have splenomegaly. Hb 8, wbc 12k, Plt 212k,
More informationLEC 6 Megaloblastic Aneamia
LEC 6 Megaloblastic Aneamia Megaloblastosis is a generalized disorder involving most rapidly growing cells, such as gastrointestinal and uterine cervical mucosal cells. The etiology of megaloblastosis
More informationBlood Cell Identification Graded
Blood Cell Identification Graded Case History The patient was a five-day-old girl with an elevated unconjugated bilirubin and a weakly positive direct antiglobulin test (DAT). Her CBC showed: WBC = 11.0
More informationThrombotic Thrombocytopenic Purpura and the Role of ADAMTS-13
Thrombotic Thrombocytopenic Purpura and the Role of ADAMTS-13 Mark Cunningham,MD Director, Hematology Laboratory Department of Pathology University of Kansas Medical Center College of American Pathologists
More informationHemolytic uremic syndrome: Investigations and management
Hemolytic uremic syndrome: Investigations and management SAWAI Toshihiro M.D., Ph.D. Department of Pediatrics, Shiga University of Medical Science Otsu, JAPAN AGENDA TMA; Thrombotic micro angiopathy STEC-HUS;
More informationThe importance of thrombocytopenia and its causes
SYSMEX EDUCATIONAL ENHANCEMENT AND DEVELOPMENT NO 4 2017 SEED HAEMATOLOGY The importance of thrombocytopenia and its causes Key words: Thrombocytopenia, thrombocytopenic, low levels of platelets What is
More informationThrombocytopenia: a practial approach
Thrombocytopenia: a practial approach Dr. med. Jeroen Goede FMH Innere Medizin, Medizinische Onkologie, Hämatologie FAMH Hämatologie Chefarzt Hämatologie Kantonsspital Winterthur Outline Introduction and
More informationNon-immune acquired haemolytic anaemias. Dr.Maysem
Non-immune acquired haemolytic anaemias Dr.Maysem Causes of Non-immune acquired haemolytic anaemias. Infections Infections can cause haemolysis in a variety of ways: -They may precipitate an acute haemolytic
More informationCase Report A Puzzle of Hemolytic Anemia, Iron and Vitamin B12 Deficiencies in a 52-Year-Old Male
Hindawi Publishing Corporation Case Reports in Hematology Volume 2013, Article ID 708489, 5 pages http://dx.doi.org/10.1155/2013/708489 Case Report A Puzzle of Hemolytic Anemia, Iron and Vitamin B12 Deficiencies
More informationMedical Policy Vitamin B12 Screening & Testing
Medical Policy Vitamin B12 Screening & Testing Subject: Vitamin B12 Screening & Testing Background: Vitamin B12 is a water-soluble vitamin that is required for proper red blood cell formation, neurological
More informationThrombotic microangiopathies and antineoplastic agents
Thrombotic microangiopathies and antineoplastic agents Paul Coppo paul.coppo@aphp.fr Service d Hématologie - Hôpital Saint-Antoine AP-HP et Université Pierre & Marie Curie Centre de Référence des Microangiopathies
More informationHematology Unit Lab 1 Review Material
Hematology Unit Lab 1 Review Material - 2018 Objectives Laboratory instructors: 1. Assist students during lab session Students: 1. Review the introductory material 2. Study the case histories provided
More informationPNH Glossary of Terms
AA Absolute neutrophil count Alendronate Allergen ALT Anemia Antibodies Anticoagulant Anticoagulation Antigen Antithymocyte globulin (ATG) Aplastic Aplastic anemia Band Bilirubin Blast cells Bone marrow
More informationTHE CLASSIFICATION OF ANEMIA*
THE CLASSIFICATION OF ANEMIA* RUSSELL L. HADEN, M.D. SUMMARY A laboratory and clinical classification of anemia has been outlined. The results of the blood study have been correlated with the clinical
More informationDiagnostic Approach to Patients with Anemia
J KMA Special Issue Diagnostic Approach to Patients with Anemia Seonyang Park, MD Department of Internal Medicine, Seoul National University College of Medicine E mail : seonpark@snu.ac.kr J Korean Med
More informationHEME 10 Bleeding Disorders
HEME 10 Bleeding Disorders When injury occurs, three mechanisms occur Blood vessels Primary hemostasis Secondary hemostasis Diseases of the blood vessels Platelet disorders Thrombocytopenia Functional
More informationA 60 year old woman with altered mental status and thrombotic microangiopathy. Josh Veatch
A 60 year old woman with altered mental status and thrombotic microangiopathy Josh Veatch Previously healthy 60 year old woman 2 3 months of fatigue following a URI, transient episodes being out of it
More information3 Ruba hussein Dr. ahmad Dr. ahmad
3 Ruba hussein Dr. ahmad Dr. ahmad The arrangement of this sheet differs from that of the record. Anemia of peripheral removal in which we are losing hemoglobin and RBCs mass and the two major Causes are:
More informationA 23 year old Caucasian male presented with shortness of breath, hypertension, bloody sputum, and a history of drug abuse (confirmed by urinalysis).
A 23 year old Caucasian male presented with shortness of breath, hypertension, bloody sputum, and a history of drug abuse (confirmed by urinalysis). He was found to have severe kidney injury requiring
More informationSafety and Efficacy of Eculizumab in Pediatric Patients With ahus, With or Without Baseline Dialysis
SP281 Safety and Efficacy of Eculizumab in Pediatric Patients With ahus, With or Without Baseline Johan Vande Walle, 1 Larry A. Greenbaum, 2 Camille L. Bedrosian, 3 Masayo Ogawa, 3 John F. Kincaid, 3 Chantal
More informationIntroduction and Approach to Anemia
2 nd lecture in Hematology by Dr.Alaa Fadhil Alwan Introduction and Approach to Anemia Anemia is defined clinically as a blood hemoglobin or hematocrit value that is below the appropriate reference range
More informationObjectives. Thrombotic Thrombocytopenic Purpura (TTP) and ADAMTS13 Testing. Disclosure
Thrombotic Thrombocytopenic Purpura (TTP) and Testing Dong Chen MD PhD Special Coagulation Laboratory Mayo Clinic-Rochester 2018 Disclosure Chair, CAP Coagulation Resource Committee Mayo Medical Laboratory
More informationDrug induced hemolysis: transfusion management Interactive case study
Drug induced hemolysis: transfusion management Interactive case study Kurt Anseeuw, MD Department of Emergency Medicine ZNA Stuivenberg Antwerp, Belgium Case 1 Male patient, 50 y History Nil Chief Complaint
More informationTaking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss
Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss Joanne Eddington, MN, FNP, AOCN Providence Oncology and Hematology Care Clinic - Eastside Blood Cell Abnormalities Abnormalities
More information* Renal insufficiencies
Thrombotic Thrombocytopenic Purpura Behzad Poopak, DCLS PhD. Tehran medical Branch Islamic Azad university bpoopak@yahoo.com Case Summary Ms. X, a 35-year year-old woman Complained of weakness, low grade
More informationGeneral Characterisctics
Anemia General Characterisctics Definition: anemia is a decrease in red blood cells. Happens due to underproduction, increased destruction or loss of red cells. Diagnosis of anemia: Hgb < 135 (men) Hgb
More informationAccepted Manuscript. No more thrombotic thrombocytopenic purpura/hemolytic uremic syndrome please. Yeong-Hau H. Lien MD, PhD S (18)
Accepted Manuscript No more thrombotic thrombocytopenic purpura/hemolytic uremic syndrome please Yeong-Hau H. Lien MD, PhD PII: S0002-9343(18)30965-3 DOI: https://doi.org/10.1016/j.amjmed.2018.10.009 Reference:
More informationTHE NECKER SYNDROME. Sarah Buckley Dan Martin January 2015
THE NECKER SYNDROME Sarah Buckley Dan Martin January 2015 TTP AND MDS (OR SOMETHING IN BETWEEN) CC: 74 yo F presenting with anemia, thrombocytopenia, renal insufficiency, and altered mental status. HxPI:
More informationFaculty of Medicine Dr. Tariq Aladily
Iron deficiency anemia The most common anemia worldwide Only 10% of ingested iron is absorbed Most dietary iron occurs in meat products Absorbed in duodenum Hepcidin By inhibiting ferroportin, hepcidin
More informationTHROMBOTIC MICROANGIOPATHY. Jun-Ki Park 7/19/11
THROMBOTIC MICROANGIOPATHY Jun-Ki Park 7/19/11 TMAs are microvascular occlusive disorders characterized by systemic or intrarenal aggregation of platelets, thrombocytopenia, and mechanical injury to erythrocytes.
More informationPutting the Pieces Together. Anne Longtine MD Internal Medicine Residency, Maine Medical Center Maine ACP Annual Meeting Clinical Vignette 9/16/2017
Putting the Pieces Together Anne Longtine MD Internal Medicine Residency, Maine Medical Center Maine ACP Annual Meeting Clinical Vignette 9/16/2017 One Week Ago: Outpatient Clinic 64 y/o female presenting
More informationTypes of Anaemias and their Management. S. Moncrieffe, Pharm.D., MPH, Dip.Ed., RPh. PSJ CE Mandeville Hotel April 27, 2014
Types of Anaemias and their Management S. Moncrieffe, Pharm.D., MPH, Dip.Ed., RPh. PSJ CE Mandeville Hotel April 27, 2014 Objectives At the end of the presentations participants should be able to: 1. Define
More informationAnemia in the elderly. Nattiya Teawtrakul MD., PhD
Anemia in the elderly Nattiya Teawtrakul MD., PhD Contents Definition of anemia in the elderly The impact of anemia in the elderly Etiology of anemia in the elderly Management of anemia in the elderly
More informationThrombotic Microangiopathies
Thrombotic Microangiopathies ASH/San Antonio Breast Cancer Symposium Review James N. George March 14, 2015 Thrombotic Microangiopathies (TMA): Everything you need to know from 5 patient stories Thrombotic
More informationHeme (Bleeding and Coagulopathies) in the ICU
Heme (Bleeding and Coagulopathies) in the ICU General Topics To Discuss Transfusions DIC Thrombocytopenia Liver and renal disease related bleeding Lack of evidence in managing critical illness related
More informationEvaluation of Anemia. Md. Shafiqul Bari Associate professor (Medicine) SOMC
Evaluation of Anemia Md. Shafiqul Bari Associate professor (Medicine) SOMC Definition Anemia is operationally defined as a reduction in one or more of the major RBC measurements Hemoglobin concentration
More informationApproach to a pale child
Approach to a pale child Dr. Dafalla Ahmed Babiker Jazan university objectives Definition of anemia Classification and causes Important points in history and physical examination Investigations. Definition
More informationSalmonella Typhi Associated Hemophagocytic Lymphohistiocytosis in a Previously Healthy 23 Years Old Woman
Article ID: WMC001751 ISSN 2046-1690 Salmonella Typhi Associated Hemophagocytic Lymphohistiocytosis in a Previously Healthy 23 Years Old Woman Author(s):Dr. Dina Khalaf, Dr. Bassem Toema, Dr. Shaker Al-sadadi,
More informationAnemia. A case-based approach. David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017
Anemia A case-based approach David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017 Recognizing trends Learning Objectives MCV, RDW, Ferritin, LDH, Reticulocytes Managing complex patients 1.
More informationSafety and Efficacy of Eculizumab in Pediatric Patients With ahus, With or Without Baseline Dialysis
SA-PO546 Safety and Efficacy of Eculizumab in Pediatric Patients With ahus, With or Without Baseline Johan Vande Walle, 1 Larry A. Greenbaum, 2 Camille L. Bedrosian, 3 Masayo Ogawa, 3 John F. Kincaid,
More informationChapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89
Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89 Presented by Jennifer Kurkulonis 1 FOUR MAJOR TYPES OF BLOOD CELLS White blood cells
More information2013 AAIM Pathology Workshop
2013 AAIM Pathology Workshop John Schmieg, M.D., Ph.D. None Disclosures 1 Pathology Workshop Objectives Define the general philosophy of reviewing pathology reports Review the various components of Bone
More informationBBTS Advanced Clinical and laboratory case studies. Therese Callaghan
BBTS 2017 Advanced Clinical and laboratory case studies Therese Callaghan Disclaimer Nothing to disclose A 52 year old man with history of paranoid schizophrenia presents to A&E with history of abdominal
More informationISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI CLINICAL RESEARCH CENTER ALDO E FOR CELE RARE DACCO DISEASES ALDO E CELE DACCO
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI CENTRO MARIO DI NEGRI RICERCHE INSTITUTE CLINICHE FOR PHARMACOLOGICAL PER LE MALATTIE RESEARCH RARE CLINICAL RESEARCH CENTER ALDO E FOR CELE RARE DACCO DISEASES
More informationLiving with PNH 7/3/2013. Paroxysmal Nocturnal Hemoglobinuria (PNH): A Chronic, Systemic, and Life- Threatening Disease
Living with PNH Laurence A. Boxer, MD University of Michigan Case Study 15 year old awakened in the morning with chest pain and a sore throat. She experienced chest pain all day accompanied with coughing
More informationHEMATOLOGIC MORPHOLOGY- AECOM HEMATOLOGY COURSE
Log Out Help current login :lcytryn@montefiore.org HEMATOLOGIC MORPHOLOGY- AECOM HEMATOLOGY COURSE Lawrence Cytryn, M.D. - Course Director 1998 Edward Burns, M.D. Images used by permission within AECOM
More information2. Non- hemolytic anemias 3. Normocytic Normochromic Normocytic Normochromic Blood loss. (MCV<80 fl) (MCV fl) (MCV>100 fl)
Definition of Anaemia of Anaemias Approach for diagnosis of Red cell disorders any condition resulting from a significant decrease in the total body erythrocyte mass due to decrease of Hb and or RBCs Hemoglobin
More informationCase # 1. RBC Loss. CASE #1 (Continued) Blood Loss Is the Most Common Cause of Anemia. AGA Definition of Occult Blood Loss
Case # 1 A 42-yo woman with heavy menses presents with rectal bleeding. Except for pallor, exam is normal. HCT = 17.1% (normal, 36-48) HGB = 5.3 g/dl (normal, 12.0-16.0) MCV = 76 fl (normal, 82-98) RBC
More informationPeripheral Blood Smear Examination. Momtazmanesh MD. Ped. Hematologist & Oncologist Loghman General Hospital
1395 Peripheral Blood Smear Examination Momtazmanesh MD. Ped. Hematologist & Oncologist Loghman General Hospital Peripheral Blood Smear A peripheral blood smear is a snapshot of the cells that are present
More informationHematology: Challenging Cases with Your Participation COPYRIGHT
Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel Deaconess Medical Center Harvard Medical School Boston, MA Question 1 Question 1 64-year-old man is evaluated during
More informationHEMATOPOIESIS. HEMATOLOGY Introduction. Study of blood & its components Window of rest of body. Introduction
HEMATOLOGY/ HEMATOPOIESIS Introduction HEMATOLOGY Introduction Study of blood & its components Window of rest of body 1 BLOOD Raison d etre Delivery of nutrients Oxygen Food Vitamins Removal of wastes
More informationInterpreting the CBC. Robert Miller PA Assistant Professor of Clinical Pediatrics and Family Medicine USC Keck School of Medicine Retired
Interpreting the CBC Robert Miller PA Assistant Professor of Clinical Pediatrics and Family Medicine USC Keck School of Medicine Retired The CBC 3 Cell Lines RBCs WBCs Platelets Assess general health Make
More informationThrombotic thrombocytopenic purpura: 2008 Update
MEDICAL GRAND ROUNDS CME CREDIT MARK A. CROWTHER, MD Director, Division of Hematology, McMaster University, Hamilton, Ontario, Canada JAMES N. GEORGE, MD Hematology-Oncology Section, Department of Medicine,
More informationPREGNANCY ASSOCIATED THROMBOTIC THROMBOCYTOPENIC PURPURA AND ACUTE KIDNEY INJURY
VII, 2013, 2 33 A, PREGNANCY ASSOCIATED THROMBOTIC THROMBOCYTOPENIC PURPURA AND ACUTE KIDNEY INJURY M. Lubomirova Clinic of Nephrology, University Hospital Aleksandrovska So a : ( ), /HELLP, (AFLP) (TTP)
More informationRituximab as first-line treatment for acquired thrombotic thrombocytopenic purpura
Clinical Note Rituximab as first-line treatment for acquired thrombotic thrombocytopenic purpura Journal of International Medical Research 2017, Vol. 45(3) 1253 1260! The Author(s) 2017 Reprints and permissions:
More informationHEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY
HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY HEMATOCRIT Hematocrit is a measure of the percentage of the total blood volume that is made up by the red blood cells The hematocrit can be determined directly
More informationPulmonary Tumor Thrombotic Microangiopathy
Pulmonary Tumor Thrombotic Microangiopathy Report of 3 Cases and Review of the Literature Eukene Gainza, MD, Sara Fernández, MD, Daniel Martínez, MD, Pedro Castro, MD, PhD, Xavier Bosch, MD, PhD, José
More informationBone Marrow Study in Patients of Pancytopenia
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 7 Ver. II (July. 2017), PP 109-113 www.iosrjournals.org Bone Marrow Study in Patients of Pancytopenia
More informationCase report 24 th Summer School of Internal Medicine 2015
Case report 24 th Summer School of Internal Medicine 2015 Goldmannová D., Horák P., Skácelová M. IIIrd Internal Clinic - endocrinology, diabetology, rheumatology, nephrology University hospital Olomouc,
More informationUpdates in the Management of Anemia in Cancer. Taylor M. Ortiz, MD May 19, 2017
Updates in the Management of Anemia in Cancer Taylor M. Ortiz, MD May 19, 2017 Objectives Recall common causes of anemia in patients with cancer Understand risks/benefits of blood transfusion in patients
More informationDiscussion. Case conference. Anemia. The basic evaluation of a patient newly diagnosed with anemia. Speaker : R2 趙劭倫 Supervisor : VS 林立偉
Case conference Discussion Speaker : R2 趙劭倫 Supervisor : VS 林立偉 990123 The basic evaluation of a patient newly diagnosed with anemia Anemia CBC Reticulocyte count : reflects activity in the bone marrow
More informationAcute Immune Thrombocytopenic Purpura (ITP) in Childhood
Acute Immune Thrombocytopenic Purpura (ITP) in Childhood Guideline developed by Robert Saylors, MD, in collaboration with the ANGELS team. Last reviewed by Robert Saylors, MD September 22, 2016. Key Points
More informationIdelalisib treatment is associated with improved cytopenias in patients with relapsed/refractory inhl and CLL
Idelalisib treatment is associated with improved cytopenias in patients with relapsed/refractory inhl and CLL Susan M O Brien, Andrew J Davies, Ian W Flinn, Ajay K Gopal, Thomas J Kipps, Gilles A Salles,
More informationDairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam FK-USU/RS H.Adam Malik Medan 2009
HAEMOLYTIC ANAEMIA Dairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam FK-USU/RS H.Adam Malik Medan 2009 WHEN BY THEN Hb 9 g% transfusion
More informationAPPROACHING TO PANCYTOPENIA
APPROACHING TO PANCYTOPENIA P A T C H A R E E K O M V I L A I S A K, M. D. A S S I S T A N T P R O F E S S O R D I V I S I O N O F P E D I A T R I C H E M A T O L O G Y O N C O L O G Y, D E P A R T M E
More informationCase Report ISSN:
Case Report ISSN: 2581-6756 N-Acetylcysteine for Refractory Acquired Thrombotic Thrombocytopenic Purpura: New Dosage Approaches Ignacio Español 1, Juan Diego Leal 1, José Ros 2, José Sanmartín 2, María
More informationClinical study of 9 patients with acquired thrombotic thrombocytopenic purpura
Journal of Clinical and Experimental Medicine VOL.1,ISS.3,DEC 2017,1-5 ONLINE ISSN: 2523-2835 www.jocem.org PRINT ISSN: 2521-0084 DOI:10.29422/jocem.2017.03.001 Abstract: Clinical study of 9 patients with
More informationBone marrow examination in cases of pancytopenia
International Journal of Research in Medical Sciences Shah P et al. Int J Res Med Sci. 2017 Apr;5(4):1494-1498 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Original Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20171253
More informationNeutropenia Following Intravenous Immunoglobulin Therapy in Pediatric Patients with Idiopathic Thrombocytopenic Purpura
ORIGINAL ARTICLE IJBC 2014;6(2): 81-85 Neutropenia Following Intravenous Immunoglobulin Therapy in Pediatric Patients with Idiopathic Thrombocytopenic Purpura Ansari S * 1, Shirali A 1, Khalili N 1, Daneshfar
More informationDr Anzo William Adiga
Anemia Dr Anzo William Adiga +256777363201 anzoism2008@gmail.com Definition of Anemia Deficiency in the oxygen-carrying capacity of the blood due to a diminished erythrocyte mass. May be due to: Erythrocyte
More informationTMA in HUS and TTP: new insights
TMA in HUS and TTP: new insights Daan Dierickx University Hospitals Leuven, Department of Hematology, Belgium 20th Annual Meeting Belgian Society on Thrombosis and Haemostatis Antwerpen, 22 th November
More informationTreating breakthrough bleeds: A new approach
Treating breakthrough bleeds: A new approach Using Bypassing Agents With HEMLIBRA Prophylaxis Indication HEMLIBRA is indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes
More informationAcute haemolysis and appearance of PNH-like clones in patients with vitamin B12 deficiency and iron deficiency after iron dextran administration
Acute haemolysis and appearance of PNH-like clones in patients with vitamin B12 deficiency and iron deficiency after iron dextran administration Chun-Liang Lin 1, Chin-Chan Lin 1,Wen-Jyi Lo 2,Yu-Chien
More information